Outcomes of NAFLD and MAFLD: Results from a community-based, prospective cohort study

Prevalence and Risk Factors of Metabolic Associated Fatty Liver Disease in Xinxiang, China

(2020) Hongbin Li et al.   International Journal of Environmental Research and Public Health

Metabolic syndrome, but not non‐alcoholic fatty liver disease, increases 10‐year mortality: A prospective, community‐cohort study

(2019) Madunil A. Niriella et al.   LIVER INTERNATIONAL

Components of metabolic syndrome increase the risk of mortality in nonalcoholic fatty liver disease (NAFLD)

(2018) Pegah Golabi et al.   MEDICINE

Increased risk of mortality by fibrosis stage in nonalcoholic fatty liver disease: Systematic review and meta-analysis

(2017) Parambir S. Dulai et al.   HEPATOLOGY

Fibrosis stage but not NASH predicts mortality and time to development of severe liver disease in biopsy-proven NAFLD

(2017) Hannes Hagström et al.   JOURNAL OF HEPATOLOGY

Incidence and risk factors for non-alcoholic fatty liver disease: A 7-year follow-up study among urban, adult Sri Lankans

(2017) Madunil A. Niriella et al.   LIVER INTERNATIONAL

Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention

(2017) Zobair Younossi et al.   Nature Reviews Gastroenterology & Hepatology

Fibrosis stage is the strongest predictor for disease-specific mortality in NAFLD after up to 33 years of follow-up

(2015) Mattias Ekstedt et al.   HEPATOLOGY

The global NAFLD epidemic

(2013) Rohit Loomba et al.   Nature Reviews Gastroenterology & Hepatology

In patients with non-alcoholic fatty liver disease, metabolically abnormal individuals are at a higher risk for mortality while metabolically normal individuals are not

(2012) Zobair M. Younossi et al.   METABOLISM-CLINICAL AND EXPERIMENTAL

Prevalence and risk factors for non-alcoholic fatty liver disease among adults in an urban Sri Lankan population

(2009) Anuradha S Dassanayake et al.   JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY